PT Indofarma Tbk Stock price

Equities

INAF

ID1000068406

Pharmaceuticals

End-of-day quote INDONESIA S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
322 IDR -9.55% Intraday chart for PT Indofarma Tbk -18.27% -44.48%
Sales 2021 2,902B 183M Sales 2022 1,144B 72.08M Capitalization 3,564B 225M
Net income 2021 -37.58B -2.37M Net income 2022 -428B -26.99M EV / Sales 2021 2.46 x
Net Debt 2021 224B 14.11M Net Debt 2022 357B 22.52M EV / Sales 2022 3.43 x
P/E ratio 2021
-184 x
P/E ratio 2022
-8.32 x
Employees 1,086
Yield 2021 *
-
Yield 2022
-
Free-Float 19.34%
More Fundamentals * Assessed data
Dynamic Chart
PT Indofarma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
PT Indofarma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PT Indofarma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Indofarma Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PT Indofarma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PT Indofarma Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Indofarma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Indofarma Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Indofarma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Pt Indofarma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Achiko AG Establishes A Joint Venture with PT Indonesia Farma Medis for the Production and Distribution of Its Test Platform for Covid-19 in Indonesia CI
Pt Indofarma Persero Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
PT Indofarma Persero Tbk Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Pt Indofarma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Pt Indofarma Persero Tbk Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
More news
1 day-9.55%
1 week-18.27%
Current month-16.58%
1 month-17.01%
3 months-50.46%
6 months-34.82%
Current year-44.48%
More quotes
1 week
322.00
Extreme 322
436.00
1 month
322.00
Extreme 322
436.00
Current year
322.00
Extreme 322
595.00
1 year
322.00
Extreme 322
730.00
3 years
322.00
Extreme 322
3 490.00
5 years
322.00
Extreme 322
7 350.00
10 years
120.00
Extreme 120
7 350.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-01-29
Director of Finance/CFO 56 22-05-30
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 57 15-04-07
Director/Board Member 63 20-07-28
Chairman 62 21-05-19
More insiders
Date Price Change Volume
24-03-27 322 -9.55% 431,100
24-03-26 356 -9.64% 363,100
24-03-25 394 -9.63% 478,500
24-03-22 436 +9.55% 2,360,200
24-03-21 398 +1.02% 97,600

End-of-day quote INDONESIA S.E., March 26, 2024

More quotes
PT Indofarma Tbk is an Indonesia-based company, which is engaged in the healthcare industry. The Company's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The Company carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.
More about the company
  1. Stock
  2. Equities
  3. Stock PT Indofarma Tbk - INDONESIA S.E.